This content is intended for Healthcare Professionals only.
It is a source of continuing educational content for you and your patients. You must not use the content for any other purpose. By clicking ‘yes’ below you are agreeing that you are a registered dental healthcare professional with a current license number and are entitled to access this content. Your use of this content is also subject to our “Terms of Use” and “Privacy Policy”.
Comparative Effects of 2 Chemotherapeutic Mouthrinses
Comparative Effects of 2 Chemotherapeutic Mouthrinses
on the Development of Supragingival Dental Plaque and Gingivitis1,2
Conclusion
LISTERINE® Antiseptic produces gingivitis reductions comparable to Peridex™ at 6 months (including gingivitis in posterior regions).
Comparative Effects of 2 Chemotherapeutic Mouthrinses on the Development of Supragingival Dental Plaque and Gingivitis1,2
- Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579.
Peridex™ vs LISTERINE® for Gingivitis and Dental Plaque
Objective
Determine the efficacy of 2 mouthrinses - LISTERINE® Antiseptic and Peridex™ - used as supplements to regular oral hygiene measures in reducing supragingival dental plaque and gingivitis (N=124).
Methodology
Double-blind, controlled, parallel design clinical study of healthy male and female subjects (aged ≥21 years) with preexisting plaque and gingivitis but without evidence of periodontitis.
overholsermethodology.png
Results
At 6 months, gingivitis development was inhibited by 35.9% in the LISTERINE® Antiseptic group and by 30.5% in the Peridex™ group, when compared to the hydroalcohol control (P<0.001).
At 6 months, gingivitis development—in posterior regions—was inhibited by 33.2% and 34.4% in the LISTERINE® Antiseptic group and by 26.6% and 33.8% in the Peridex™ group, when compared to the hydroalcohol control (P<0.001).2
2.3.4_overholserchart.png
Conclusion
LISTERINE® Antiseptic produces gingivitis reductions comparable to Peridex™ at 6 months (including gingivitis in posterior regions).
*LISTERINE® Antiseptic is not indicated for use in the treatment of xerostomia.
†During the study, subjects followed their usual oral hygiene and dietary habits.
References: 1. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579. 2. Data on file, Johnson & Johnson Consumer Inc.
By registering, you agree to receive additional transactional, marketing/promotional and sample material from the Johnson's Baby Professional website. Your personal information will be used to fulfill your request for samples and/or patient education materials. Your information will be shared only with JNTL Consumer Health (Philippines) Inc., its affiliates, and any third parties working on their behalf to fulfill your request, and will be governed by our site's Privacy Policy.
By registering, you agree to receive additional transactional, marketing/promotional and sampling material from the Listerine Healthcare Professional website. Your personal information will be used to fulfill your request for samples and/or patient education materials. Your information will be shared only with JNTL Consumer Health (Philippines) Inc., its affiliates, and any third parties working on their behalf to fulfill your request, and will be governed by our site's Privacy Policy.
Looks like you have an existing account with us. We have made some changes to our site and we need you to create a new password in order to login. Click send to recieve an email with instructions on how to create your new password.
You cannot log in until your email address is verified. Please click the email verification link in the message we have sent you, or use the form below to get another message.
All Fields required, unless otherwise indicated
Will be used as your user name
By submitting your information above, you agree that the information you provide will be governed by our site's Privacy Policy.